Devicare has signed a participative loan worth €2 million from the Innova Global line by Avançsa, assigned to the Business and Expertise Department, with the option to convert the investment into Series A stock in the mid-term.

With this new economic injection, Devicare will continue the strategic development plan of new medical solutions under the Remote Patient Monitoring concept, which simply and economically places patients at the centre of their own healthcare management, known as patient empowerment, as well as the corresponding clinical studies and trials for the expansion throughout the European and North American markets. Currently, the company has distributors in Spain, Mexico, Colombia, France and UK.

Francesc Cabezas, the Devicare’s financial director, explains that “we’re now completely in the validation phase with a business model that perfectly fits Avançsa’s strategic objectives: an entrepreneurial project with an extremely innovative component and an excellent potential for international expansion, impact in the territory and feasibility.”

Recently, Devicare and Parc Tauli have announced that it will co-develop medical devices which allow patients with chronic mental diseases to monitor their own health.

More information is available on the Devicare website.

Photo: Francesc Cabezas, in the right, with Avançsa management - © Devicare